Why the study?
Does efonidipine 40 mg improve 24-hour systolic blood pressure and heart rate profiles in patients with essential hypertension?
Observational (n=37)
No
Does efonidipine 40 mg improve 24-hour systolic blood pressure and heart rate profiles in patients with essential hypertension?
Efonidipine 40 mg effectively reduces 24-hour systolic blood pressure and heart rate, while favorably altering the diurnal to nocturnal SBP ratio in both dipper and non-dipper hypertensive patients.
BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the effects of an L- and T-type calcium channel blocker (CCB) on 24-hour systolic blood pressure (24-hour SBP) and heart rate (24-hour HR) profiles in essential hypertensive patients. SUBJECTS AND METHODS: Thirty-seven consecutive patients were enrolled in this study. The 24-hour SBP and HR were recorded before and after treatment with efonidipine (L- and T-type CCB, 40 mg), after waking. Changes in 24-hour SBP and HR and the diurnal to nocturnal SBP ratio were measured. The best-fit curves of changes in SBP and HR were depicted using a periodic function. RESULTS: The mean 24-hour SBP and HR decreased significantly after treatment. The diurnal to nocturnal SBP ratio in dipper-type hypertension cases decreased from 16.7±6.1% to 8.3±9.8% (p<0.05), whereas in non-dipper hypertension cases, it increased from 2.3±2.9% to 7.7±5.1% (p<0.01). The antihypertensive effect was minimal at 5.0 hours after drug administration and it slowly recovered at a constant rate (2.1 mm Hg/h) over 12 hours in dipper cases. The median 24-hour changes in HR in the dipper and non-dipper cases were -2.3/min and -5.4/min, respectively. A continuous reduction in the change in HR was seen from 3.5 to 23 hours after drug administration. CONCLUSION: The antihypertensive action of efonidipine was characterized by a slow recovery of the SBP decrease at a constant rate (2.1 mm Hg/h) and a non-administration time dependent reduction in 24-hour HR.
No takes yet. Share an insight, caveat, or question.
Komukai et al. (2012) conducted an observational in Essential hypertension (n=37). Efonidipine vs. Baseline (before treatment) was evaluated on 24-hour mean systolic blood pressure (MD -9.3 mm Hg, p=<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: